Radiotherapy Planning, Computer-AssistedProton TherapyPhysical Therapy ModalitiesRadiotherapy DosageRadiometryFilm DosimetryRadiation InjuriesRadiotherapy, Intensity-ModulatedRadiation DosageAntineoplastic AgentsRadiotherapy, ConformalRadiation, IonizingDose-Response Relationship, RadiationRadiation ToleranceRadiotherapyTreatment OutcomeRadiationCombined Modality TherapyCell Line, TumorNeoplasmsRadiation ProtectionRadiation OncologyDrug Screening Assays, AntitumorRadiation MonitoringPhantoms, ImagingTime FactorsDoxorubicinDose FractionationGenetic TherapyRadiotherapy, AdjuvantRadiation PneumonitisApoptosisCisplatinBrachytherapyRadiation-Sensitizing AgentsDrug Resistance, NeoplasmCell SurvivalAntineoplastic Agents, PhytogenicNeoplasms, Radiation-InducedGamma RaysRadiation Injuries, ExperimentalAntibiotics, AntineoplasticRadiosurgeryDrug Delivery SystemsCosmic RadiationBrain NeoplasmsTumor Cells, CulturedXenograft Model Antitumor AssaysBreast NeoplasmsMice, NudeDNA DamageRadiotherapy, Computer-AssistedDrug CarriersCranial IrradiationAntineoplastic Combined Chemotherapy ProtocolsEtoposideHead and Neck NeoplasmsParticle AcceleratorsPaclitaxelNeoplasm Recurrence, LocalRadiotherapy, Image-GuidedCell ProliferationRadiation-Protective AgentsBackground RadiationEllipticinesFluorouracilRadiodermatitisProstatic NeoplasmsCamptothecinUltraviolet RaysRadiotherapy, High-EnergyCarcinoma, Squamous CellLung NeoplasmsAdenocarcinomaDose-Response Relationship, DrugNeoplasm StagingOrgans at RiskTumor BurdenDrug Resistance, MultipleInhibitory Concentration 50P-GlycoproteinCell CycleRadiation EffectsCobalt RadioisotopesMolecular StructureRetrospective StudiesChemoradiotherapySurvival AnalysisDrug Design